Axsome Therapeutics to Present Data and Post-Hoc Analyses on Auvelity® and Sunosi® at the 2023 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

Data on Auvelity demonstrating improved functioning in major depressive disorder Data on Sunosi demonstrating improved cognitive function in patients with excessive daytime sleepiness associated with... | May 30, 2023

Related Keywords

Miami ,Florida ,United States ,Texas ,Japan ,Geneva ,Genè ,Switzerland ,China ,New York ,American ,Gregory Mattingly ,Rakesh Jain ,Eileen Leary ,Andrew Cutler ,Samantha Floam ,Darren Opland ,Zachariah Thomas ,Mark Jacobson ,Clinical Professor Of Psychiatry At Washington University ,Axsome Therapeutics Inc ,Md Texas Tech University School Of Medicine ,World Trade Center ,National Survey On Drug ,Sk Biopharmaceuticals Co Ltd ,Nasdaq ,Neuroscience Education Institute ,Midwest Research Group ,National Institutes Of Health ,American Society Of Clinical Psychopharmacology ,Mental Health Services Administration ,World Health Organization ,Us Drug Enforcement Agency On ,Drug Administration ,Global Health ,Behavioral Health Statistics ,Corporate Communications ,American Society ,Clinical Psychopharmacology ,Annual Meeting ,Cognitive Health ,Apnea Participants During ,Randomized Placebo Controlled ,Associate Clinical Professor ,Medical University ,Chief Medical Officer ,Neuroscience Education ,Significantly Improved Functioning ,Major Depressive Disorder ,Sheehan Disability ,Patient Reported Insomnia Symptoms ,Withdrawal Symptoms After Discontinuation ,Tech University School ,Major Depressive Disorder Disease ,Patient Characteristics Associated ,Inadequate Treatment Experience ,Washington University ,Midwest Research ,Excessive Daytime Sleepiness ,Real World Study ,Obstructive Sleep Apnea ,Preclinical Pharmacology ,Potential Mechanisms ,Gregory Parks ,Cognitive Function ,Cognitive Impairment Associated ,National Institutes ,Breakthrough Therapy ,Prescribing Information ,Boxed Warning ,Enforcement Agency ,Full Prescribing Information ,Medication Guide ,Axsome Therapeutics ,Economic Burden ,Mental Health Services ,Drug Use ,Substance Abuse ,Nc Stock Exchange ,News ,Information ,Press Release ,Data ,N ,Auvelity ,Emonstrating ,Mproved ,Functioning ,Major ,Depressive ,Disorder ,Vsunosi ,Cognitive ,Junction ,Patients ,Ith ,Excessive ,Daytime ,Sleepiness ,Ssociated Axsm Us05464t1043 ,